Daiken Bio
This article coincides in timing and pattern with contributions by the same user which have been determined to be AI-generated, and has no significant contributions by other editors. It is presumed to have also been AI-generated, and may be assumed to violate Wikipedia's policies and guidelines. If no editor takes responsibility for it within a five-day grace period, this article may be deleted. To object to proposed deletion, an editor may take responsibility for the content and assume the onus to achieve consensus for its inclusion. Assuming responsibility requires that all content and its sources be closely reviewed, and reworked as needed, to ensure that they comply with polices and guidelines. This may involve checking that the cited sources support the content and are reliable, determining whether the content is due for inclusion, and rewriting the content to revise any tone issues and resolve possible copyright violations. Once this has been done, this template may be removed. The nominator also gave the following reason for this proposed deletion:
Find sources: "Daiken Bio" – news · newspapers · books · scholar · JSTOR Reviewer tools: guideline project (talk • log) Move: draft space userfy The article may be deleted if this message remains in place for five days, i.e., after 17:32, 4 August 2026 (UTC). Nominator: Please consider notifying the author if active: {{subst:prodwarningLLM|Daiken Bio|concern=[[WP:LLMPRV|Presumptive removal of LLM-generated content]], see [[Wikipedia:AI noticeboard#User:Heeheemalu|Wikipedia:AI noticeboard § User:Heeheemalu]]. Feel free to reinstate by following [[WP:LLMPRVOBJ|the procedures for disputing presumptive removal of LLM-generated content]].}} ~~~~ |
Native name | 大研生醫國際股份有限公司 |
|---|---|
| Type | Public (Taiwan over-the-counter) |
| TWSE: 7780[1] | |
| Industry | Health supplements, biotechnology |
| Founded | June 20, 2018 |
| Founder | Lin Dong-qing (林東慶) |
| Headquarters | 12F, No. 37, Section 3, Roosevelt Road, Daan District, , |
Key people | Chairman: Chang Chia-ming (張家銘); CEO: Lin Dong-qing (林東慶) |
| Products | Omega-3 fish oil, lutein, probiotics, collagen supplements |
| Website | www |
Daiken Bio, officially known as Daiken Biomedical Co., Ltd. (Chinese: 大研生醫國際股份有限公司), is a Taiwanese health supplement company established in June 2018.[2] The company focuses on the research, development, production, and sales of nutritional products formulated with clinically tested ingredients.[3]
History
[edit]Daiken Bio was founded by pharmacist Lin Dong-qing (林東慶), who invested ten months of effort to launch the company's first product, a premium German fish-oil supplement rich in Omega-3 fatty acids.[4] The company positions itself as a family-oriented enterprise committed to safety and efficacy, selecting internationally patented raw materials and leveraging a research team of doctors and scientists with credentials from institutions such as the University of Rochester, National Taiwan University, Academia Sinica, University of Tokyo, Cornell, Harvard Medical School, and Johns Hopkins University.[5]
Daiken Bio is also publicly listed on Taiwan's over-the-counter (OTC) market under code 7780.[6] As of mid-2025, the company's authorized capital reached approximately NT$600 million, under the leadership of Chairman Chang Chia-ming and CEO Lin Dong-qing.[7][8]
Products and Recognition
[edit]The company's product lines include Omega-3 fish oil, lutein, probiotics, collagen, and other supplements targeting various age groups and health needs. Daiken emphasizes clinical evidence and stringent quality control, with products tested through international-standard laboratories.[9]
In 2022, its flagship product, the Daiken Fish Oil Concentrate, received a gold award for taste and quality from the International Taste Institute, affirmed by an international panel of chefs and sommeliers.[10]
Corporate Social Responsibility
[edit]Daiken Bio places high value on corporate social responsibility. The company has partnered with organizations such as the Eden Social Welfare Foundation, World Vision, the Taiwan Fund for Children and Families, and other NGOs to donate probiotic supplements, fish oil, and multi-vitamins to benefit the elderly, children, and disadvantaged groups in Taiwan and beyond. Daiken has also undertaken environmental initiatives, such as planting trees in collaboration with environmental groups to promote sustainability.[11]
See also
[edit]References
[edit]- ↑ "7780:Taipei Stock Quote - Daiken Biomedial Co Ltd". Bloomberg News. Retrieved 8 September 2025.
- ↑ 何秀玲 (2025-09-02). "大研生醫轉上市掀申購熱潮 中籤率僅1.44%". Central News Agency (Taiwan) (in Chinese (Taiwan)). Retrieved 2025-09-08.
- ↑ 楊筠 (2025-09-06). "頭家開講／交友創業16年後 他們因三高創下13億元年收 大研生醫董事長 張家銘". Mirror Media (in Chinese (Taiwan)).
- ↑ "大研生醫品牌使命 (About Daiken Bio)". Daiken Bio. Retrieved 6 September 2025.
- ↑ "大研生醫品牌研究團隊 (Daiken research team)". Daiken Bio. Retrieved 6 September 2025.
- ↑ 侯思蘋 (2025-08-22). "大研生醫9月9日上市 承銷價158元". United Daily News (in Chinese (Taiwan)). Retrieved 2025-09-08.
- ↑ "大研生醫公司資料 (Company profile)". WantGoo. Retrieved 6 September 2025.
- ↑ "Daiken Biomedical Co. Ltd. profile". EMIS. Retrieved 6 September 2025.
- ↑ "大研生醫品牌使命". Daiken Bio. Retrieved 6 September 2025.
- ↑ "Daiken Fish Oil Concentrate International Taste Institute Award". International Taste Institute. Retrieved 6 September 2025.
- ↑ "大研生醫公益活動 (Corporate social responsibility)". Daiken Bio. Retrieved 6 September 2025.